Advertisement
Document › Details
Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA.
Agilent Technologies Inc. (NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent President and CEO Mike McMullen.
Ballmer will lead the corporate-development team in identifying, developing, and evaluating merger-and-acquisition plans globally, as well as program management of integrations. She also will lead enterprise strategy while collaborating with Agilent businesses groups to drive critical growth initiatives across the company. Ballmer will serve as a key member of the executive staff and as an adviser to the CEO to help shape the company’s overall strategic direction.
"With nearly 20 years in the biotech industry — the last two being at Agilent — Allison brings a wealth of experience to this role. Her depth of knowledge in global business and marketing will serve Agilent well as we look to continue our Build-and-Buy growth strategy," McMullen said.
Prior to joining Agilent in May 2018 as vice president of Business Development and Strategy for the company’s Diagnostics and Genomics business, Ballmer spent nearly a decade of her career at Switzerland-based Roche, a multinational health-care company that operates pharmaceutical and diagnostics divisions.
She currently holds the role of lead director of the board of directors at Mission Bio, a California venture-backed company focused on genomics and precision medicine.
Ballmer holds a Bachelor of Science in mechanical engineering from Virginia Polytechnic Institute and State University.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
Media Contact
Tom Beermann
Agilent Technologies
+1 408 553 2914
tom.beermannt@agilent.com
Investor Contact
Ankur Dhingra
Agilent Technologies
+1 408 345 8948
ankur_dhingra@agilent.com
Record changed: 2023-06-05 |
Advertisement
More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (5/11/26). "Press Release: Agilent to Participate in Jefferies Global Healthcare Conference". Santa Clara, CA....
- [2] Agilent Technologies Inc.. (5/4/26). "Press Release: Agilent Names Michael Buckner as Chief Legal Officer". Santa Clara, CA....
- [3] Agilent Technologies Inc.. (4/14/26). "Press Release: Agilent Partners with OmixAI to Expand AI-Driven Proteomics in South Korea". Seoul....
- [4] Agilent Technologies Inc.. (4/2/26). "Press Release: Agilent Opens Customer Experience Center in Mumbai". Navi Mumbai....
- [5] Agilent Technologies Inc.. (3/11/26). "Press Release: Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States". Santa Clara, CA....
- [6] Agilent Technologies Inc.. (3/9/26). "Press Release: Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions". Santa Clara, CA & San Francisco, CA....
- [7] Agilent Technologies Inc.. (2/25/26). "Press Release: Agilent Reports First-Quarter Fiscal Year 2026 Financial Results". Santa Clara, CA....
- [8] Agilent Technologies Inc.. (2/23/26). "Press Release: Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (2/11/26). "Press Release: Agilent Presents Boehringer Ingelheim with Inaugural 2025 Instrument Trade-In Impact Award". Santa Clara, CA....
- [10] Agilent Technologies Inc.. (2/11/26). "Press Release: Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top



![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)




![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)


